Clinical outcome of anaplastic thyroid carcinoma treated with radiotherapy of once- and twice-daily fractionation regimens.
about
Long-term results of radiotherapy in anaplastic thyroid cancerRadiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base.Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies.Patterns of failure in anaplastic and differentiated thyroid carcinoma treated with intensity-modulated radiotherapyAnaplastic thyroid cancer: multimodal treatment results.Short course high dose radiotherapy in the treatment of anaplastic thyroid carcinomaTargeted therapy of VEGFR2 and EGFR significantly inhibits growth of anaplastic thyroid cancer in an orthotopic murine model.Anaplastic thyroid cancer: a review of epidemiology, pathogenesis, and treatment.Treatment outcome of patients with anaplastic thyroid cancer: a single center experienceAnaplastic Thyroid Cancer: Experience of the Philippine General HospitalApproach to the patient with anaplastic thyroid carcinoma.Anaplastic Thyroid Carcinoma, Version 2.2015.The role of chemotherapy and latest emerging target therapies in anaplastic thyroid cancer.Histone deacetylase enzyme silencing using shRNAs enhances radiosensitivity of SW579 thyroid cancer cellsAnaplastic thyroid carcinoma: pathogenesis and emerging therapies.Management of invasive well-differentiated thyroid cancer: an American Head and Neck Society consensus statement. AHNS consensus statement.Treatment of patients with anaplastic thyroid cancer during the last 20 years: whether any progress has been made?Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies.Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma.Radiotherapy in anaplastic thyroid carcinoma: An Australian experience.Neutron radiation therapy for advanced thyroid cancers.Simvastatin Inhibits Cell Proliferation and Migration in Human Anaplastic Thyroid Cancer.Anaplastic thyroid carcinoma: Failure of conventional therapy but hope of targeted therapy.Anaplastic thyroid cancer and hyperfractionated accelerated radiotherapy (HART) with and without surgery.Anaplastic and poorly differentiated thyroid carcinoma: therapeutic strategies and treatment outcome of 52 consecutive patients.Evidence from an updated meta-analysis of the prognostic impacts of postoperative radiotherapy and chemotherapy in patients with anaplastic thyroid carcinoma.Anaplastic thyroid cancer: the addition of systemic chemotherapy to radiotherapy led to an observed improvement in survival--a single centre experience and review of the literature.Guidelines for the management of thyroid cancer
P2860
Q30317480-F523B350-D4D2-4C43-BDDC-98E87D275794Q31151565-283DA74A-7E25-4AC2-9690-CC70F5C27D58Q33691759-5D7A860D-C7B1-427D-A953-DA5F64DD438EQ33840202-44C80A06-7AEF-4856-AB54-60A77B89A75AQ33988335-4A6D3051-F1AB-44D4-AB30-5735F61AABE3Q34425352-C2D6A115-B0EC-4ACA-9C1E-D69CB95140D8Q34810321-B2B1921A-C695-410E-876E-A8CC4C227CB6Q35104726-772457D0-B1A4-4D22-8F19-2E7720E0A09FQ35767404-DF7FF935-755F-4B32-BCE8-664B3FB3647CQ35868242-5B374FB6-75E8-4FE4-9F80-6D23BA8E70A4Q36134835-CC422453-0C7F-4428-B62E-65B7A6670F13Q37179204-A709391B-72AB-466A-943D-0B8EC25FD1A7Q37209593-B3FDF93F-CCCF-4ACA-8740-E0C4C885E8ABQ37297635-10D60CB9-F0F8-4561-A3C4-01948F3934A3Q37526750-33677DDD-2D3C-4035-B297-C6AB2B57870AQ38182494-EB2E01BF-E629-453F-89D7-5C9EC8AAD1C9Q38217116-2EE85C53-8727-4808-8DF5-AF137093FB6CQ38657760-6F43F087-C7D1-4169-83BE-73B034E0D4E9Q38798863-277A10B0-258F-463A-AA4C-9AA19F61086AQ38848568-455B7946-F096-4E0E-8B2C-2CF53A876EBDQ39456136-04FFCF5E-D792-4630-BF6D-1DB70EEDA6BDQ47298592-5300AB8B-DDC2-4787-B20E-B4EC4627E4AFQ47631967-D3B96F4F-8AA5-4748-919F-F13D848518A1Q48212492-7FDD596C-3DDB-4ABF-BFCF-278D3774DE1FQ51043512-5EC0FF0C-2D2F-4250-A0B3-4C26605ECA14Q55018380-C58E3990-4858-4B5C-A562-2B2423081605Q55712413-20680118-355B-4AAB-BBBC-A1EC599473C1Q56554243-1E5EB91E-9C18-46B7-9BF0-84AE4B8A945C
P2860
Clinical outcome of anaplastic thyroid carcinoma treated with radiotherapy of once- and twice-daily fractionation regimens.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Clinical outcome of anaplastic ...... -daily fractionation regimens.
@ast
Clinical outcome of anaplastic ...... -daily fractionation regimens.
@en
type
label
Clinical outcome of anaplastic ...... -daily fractionation regimens.
@ast
Clinical outcome of anaplastic ...... -daily fractionation regimens.
@en
prefLabel
Clinical outcome of anaplastic ...... -daily fractionation regimens.
@ast
Clinical outcome of anaplastic ...... -daily fractionation regimens.
@en
P50
P356
P1433
P1476
Clinical outcome of anaplastic ...... -daily fractionation regimens.
@en
P2093
James Brierley
Yongjin Wang
P304
P356
10.1002/CNCR.22203
P407
P577
2006-10-01T00:00:00Z